Acta neurologica Belgica
-
Acta neurologica Belgica · Mar 2001
Review Clinical TrialNew generation anti-epileptics for facial pain and headache.
The prophylactic management of recurrent head and facial pains may be challenging because of lack of efficacy and/or bothersome adverse effects of available drug therapies. New generation antiepileptic drugs offer new perspectives in difficult cases. ⋯ The dose was gradually increased in steps of 25 mg up to the effective dose (mean 250 mg/d). Lamotrigine was most effective in trigeminal neuralgia and dysesthesia, but was of little utility in the other head or facial pains.
-
Neuropathic pains associated with an injury of the peripheral or central nervous system are among the most difficult to treat. One of the reasons for the therapeutic difficulties in these patients is that the pharmacological treatments are used in a uniform fashion whatever the clinical picture, while these syndromes are in fact highly heterogenous. The patients can express various combinations of painful symptoms--spontaneous (continuous and/or paroxysmal) and evoked (allodynia and/or hyperalgesia). ⋯ Such data emphasize the necessity of a thorough evaluation of patients presenting with neuropathic pains, notably by using quantitative sensory testing. Following recent advances in the understanding of the pathophysiological mechanisms underlying these painful syndromes, through experimental studies in animals, a "mechanism-based" classification and treatment of neuropathic pains can be envisaged. The main goal for clinicians is to propose new methods and strategies for identifying pathophysiological mechanisms in patients in order to validate such an approach in the clinical context.
-
Acta neurologica Belgica · Mar 2001
ReviewThalamic stimulation in neuropathic pain: 27 years later.
An overview is given of CNS mechanisms which are behind the beneficial effects of VPL-VPM thalamic stimulation in the treatment of neuropathic pain. Further research in this field is urgently needed and the recent possibility to combine Deep Brain Stimulation with positron emission tomography (PET) will certainly help to unravel the brain circuitry implicated in stimulation-produced analgesia. Brain stimulation is an artificial way to activate nervous tissue that is reversible and, when correctly applied, has few complications. The clinical results warrant a continued dissemination of brain stimulation as a treatment in well selected cases of neuropathic pain.
-
Acta neurologica Belgica · Dec 2000
Review Comparative StudyTherapeutic coma or neuroprotection by anaesthetics.
Some surgical patients are at an increased risk for developing cerebral ischaemia. A subset of these patients is believed to benefit from putative cerebroprotective effects of anaesthetic agents. ⋯ However, both animal and especially human data are very disappointing. Only the barbiturates and isoflurane have an experimental record warranting further research to delineate proper indications for their use as neuroprotective agents in surgical patients.
-
Acta neurologica Belgica · Dec 2000
ReviewThe usefulness of EEG, exogenous evoked potentials, and cognitive evoked potentials in the acute stage of post-anoxic and post-traumatic coma.
Three-modality evoked potentials (TMEPs) have been used for several years in association with the EEG as a diagnostic and prognostic tool in acute anoxic or traumatic coma. Cognitive EPs have been recently introduced. EEG and cognitive EPs provide functional assessment of the cerebral cortex. ⋯ Thus, cognitive EPs can usefully complement exogenous EPs as a prognostic tool in coma. Indeed, even if the absence of cognitive EPs in comatose patients does not have any prognostic value, their presence implies a very high (more than 90%) probability of consciousness recovery. The major technical challenge for the future will be the development of reliable tools for continuous EEG and TMEP monitoring.